TipRanks
Go Ultimate55% OFF

Curanex Pharmaceuticals Inc. (CURX) Financial Statements

Curanex Pharmaceuticals Inc. Financial Overview

Curanex Pharmaceuticals Inc.'s market cap is currently $8.09M. The company's EPS TTM is $-7.36; its P/E ratio is -0.70; Curanex Pharmaceuticals Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00
Operating Income$ -4.24M$ -365.06K$ -19.30K
EBITDA$ -4.14M$ -290.39K$ -17.48K
Net Income$ -4.23M$ -361.51K$ -19.20K
Balance Sheet
Cash & Short-Term Investments$ 4.97M$ 148.89K$ 74.37K
Total Assets$ 11.58M$ 517.93K$ 74.37K
Total Debt$ 346.70K$ 0.00$ 0.00
Net Debt$ -4.63M$ -148.89K$ -74.37K
Total Liabilities$ 361.04K$ 14.57K$ 14.28K
Stockholders' Equity$ 11.22M$ 503.36K$ 60.09K
Cash Flow
Free Cash Flow$ -10.48M$ -555.58K$ -120.00
Operating Cash Flow$ -10.48M$ -555.58K$ -120.00
Investing Cash Flow$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 15.31M$ 630.10K$ 72.06K

Currency in USD

Curanex Pharmaceuticals Inc. Earnings and Revenue History

-4.5M-3M-1.5M00 %0.4 %0.8 %1.2 %EarningsProfit Margin202320242025RevenueEarningsProfit Margin

Curanex Pharmaceuticals Inc. Debt to Assets

05M10M15M0 %8 %16 %24 %LiabilitiesDebt to Assets202320242025AssetsLiabilitiesDebt to Assets

Curanex Pharmaceuticals Inc. Cash Flow

-15M-10M-5M05M10M15M20M202320242025OperatingInvestingFinancing

Curanex Pharmaceuticals Inc. Forecast EPS vs Actual EPS